MedKoo Cat#: 571603 | Name: GMBS Crosslinker
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GMBS crosslinking reagent, also known as N-(Gamma-Maleimidobutyryloxy) Succinimide, is a non-cleavable, water insoluble, heterobifunctional protein crosslinker. GMBS crosslinking reagent is commonly used to crosslink haptens to carrier proteins or enzymes to antibody. GMBS crosslinking reagent's short spacer arm length of 7.3 angstroms and is less immunogenic than the MBS crosslinking reagent analog. GMBS crosslinking occurs via NHS ester and maleimide reactive groups which react with amino and sulfhydryl moites, respectively. GMBS Crosslinker is useful for making antibody drug conjugates (ADCs).

Chemical Structure

GMBS Crosslinker
GMBS Crosslinker
CAS#80307-12-6

Theoretical Analysis

MedKoo Cat#: 571603

Name: GMBS Crosslinker

CAS#: 80307-12-6

Chemical Formula: C12H12N2O6

Exact Mass: 280.0695

Molecular Weight: 280.24

Elemental Analysis: C, 51.43; H, 4.32; N, 10.00; O, 34.25

Price and Availability

Size Price Availability Quantity
100mg USD 250.00 2 Weeks
250mg USD 450.00 2 Weeks
1g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
GMBS Crosslinker; N-(gamma-Maleimidobutyryloxy)succinimide; N-Succinimidyl 4-maleimidobutyrate
IUPAC/Chemical Name
4-Maleimidobutyric acid N-succinimidyl ester
InChi Key
PVGATNRYUYNBHO-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H12N2O6/c15-8-3-4-9(16)13(8)7-1-2-12(19)20-14-10(17)5-6-11(14)18/h3-4H,1-2,5-7H2
SMILES Code
O=C(ON1C(CCC1=O)=O)CCCN2C(C=CC2=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
GMBS is a heterobifunctional cross-linker.
In vitro activity:
Finally, functionalizing OMVs with N-γ-(maleimidobutyryl)oxysuccinimide-ester (GMBS), generating ready-to-conjugate OMVs, did not affect the structural integrity of the OMVs and as such, they could be evaluated with the validated FFF-MALS method. Reference: Anal Chem. 2022 Sep 6;94(35):12033-12041. https://pubmed.ncbi.nlm.nih.gov/36007249/
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 50.0 178.42
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 280.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. van der Put RMF, Spies A, Metz B, Some D, Scherrers R, Pieters R, Danial M. Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines. Anal Chem. 2022 Sep 6;94(35):12033-12041. doi: 10.1021/acs.analchem.2c01590. Epub 2022 Aug 25. PMID: 36007249; PMCID: PMC9453738. 2. Svozilová H, Plichta Z, Proks V, Studená R, Baloun J, Doubek M, Pospíšilová Š, Horák D. RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model. Int J Mol Sci. 2021 Feb 27;22(5):2376. doi: 10.3390/ijms22052376. PMID: 33673496; PMCID: PMC7956824.
In vitro protocol:
1. van der Put RMF, Spies A, Metz B, Some D, Scherrers R, Pieters R, Danial M. Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines. Anal Chem. 2022 Sep 6;94(35):12033-12041. doi: 10.1021/acs.analchem.2c01590. Epub 2022 Aug 25. PMID: 36007249; PMCID: PMC9453738. 2. Svozilová H, Plichta Z, Proks V, Studená R, Baloun J, Doubek M, Pospíšilová Š, Horák D. RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model. Int J Mol Sci. 2021 Feb 27;22(5):2376. doi: 10.3390/ijms22052376. PMID: 33673496; PMCID: PMC7956824.
In vivo protocol:
TBD
1: Nadeau OW, Anderson DW, Yang Q, Artigues A, Paschall JE, Wyckoff GJ, McClintock JL, Carlson GM. Evidence for the location of the allosteric activation switch in the multisubunit phosphorylase kinase complex from mass spectrometric identification of chemically crosslinked peptides. J Mol Biol. 2007 Feb 2;365(5):1429-45. Epub 2006 Oct 21. PubMed PMID: 17123541; PubMed Central PMCID: PMC1852525. 2: Danczyk R, Krieder B, North A, Webster T, HogenEsch H, Rundell A. Comparison of antibody functionality using different immobilization methods. Biotechnol Bioeng. 2003 Oct 20;84(2):215-23. PubMed PMID: 12966578. 3: Matsuzawa M, Liesi P, Knoll W. Chemically modifying glass surfaces to study substratum-guided neurite outgrowth in culture. J Neurosci Methods. 1996 Nov;69(2):189-96. PubMed PMID: 8946322. 4: Myers DE, Uckun FM, Swaim SE, Vallera DA. The effects of aromatic and aliphatic maleimide crosslinkers on anti-CD5 ricin immunotoxins. J Immunol Methods. 1989 Jul 6;121(1):129-42. PubMed PMID: 2474026.